Quarry LP’s Xeris Biopharma Holdings XERS Stock Holding History

Quarry LP’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$725K	Buy	125,000 +45,000	+56%	+$298K	0.13%	123
2025 Q4	$628K	Sell	80,000 -2,500	-3%	-$19.7K	0.1%	117
2025 Q3	$672K	Sell	82,500 -80,000	-49%	-$531K	0.15%	104
2025 Q2	$759K	Buy	162,500 +91,749	+130%	+$420K	0.16%	113
2025 Q1	$388K	Buy	+70,751	New	+$286K	0.08%	205
2024 Q3	–	Sell	-30,000	Closed	-$67.5K	–	2135
2024 Q2	$67.5K	Buy	30,000 +500	+2%	+$1.01K	0.02%	512
2024 Q1	$65.2K	Buy	29,500 +9,500	+48%	+$24.6K	0.01%	349
2023 Q4	$47K	Buy	+20,000	New	+$36.9K	0.01%	350

Other funds holding XERS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return